Last reviewed · How we verify
NCT05182671
Relationship Between Pelvic Angle, Femoral Anteversion, and Hip Muscle Strength Ratios in Bladder-bowel Dysfunction
trial testing Scales and measurements for bladder and bowel dysfunction, pelvic angle, proximal hip strength, femoral hip anteversion in Bladder and Bowel Dysfunction, Femoral Anteversion in 50 participants. Completed in 9 February 2024.
1 September 2023
Quick facts
| Lead sponsor | Halil Tugtepe |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 50 |
| Start date | 15 January 2022 |
| Primary completion | 1 September 2023 |
| Estimated completion | 9 February 2024 |
| Sites | 1 location across Turkey (Türkiye) |
Drugs / interventions tested
- Scales and measurements for bladder and bowel dysfunction, pelvic angle, proximal hip strength, femoral hip anteversion
Conditions studied
- Bladder and Bowel Dysfunction, Femoral Anteversion — all drugs for Bladder and Bowel Dysfunction, Femoral Anteversion →
- Bladder and Bowel Dysfunction, Hip Strength Ratios — all drugs for Bladder and Bowel Dysfunction, Hip Strength Ratios →
- Bladder and Bowel Dysfunction, Pelvic Angle — all drugs for Bladder and Bowel Dysfunction, Pelvic Angle →
Sponsor
Halil Tugtepe
Who can join
Adults 5 to 12, any sex, with Bladder and Bowel Dysfunction, Femoral Anteversion or Bladder and Bowel Dysfunction, Hip Strength Ratios. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Bladder and bowel dysfunction is a combination of lower urinary tract and bowel dysfunction seen in children over 5 years of age without identifiable or discernible neurological abnormalities. The proper functioning of the bladder, bowel, nerves, pelvic floor muscles and related anatomical structures provides the bowel and lower urinary tract function. Dysfunction of any structure of the pelvic floor can potentially cause to bladder and bowel dysfunction. The ability of the pelvic floor muscles to perform the correct contraction and relaxation function is also closely related to the position of the pelvis, muscle strength of the hip muscles, and femoral anteversion. Disruption of one of the links forming the chain causes a change in the mobility and stability of all mechanically related structures and may affect the optimal force that the pelvic floor muscles can produce. As far as investigators know, there is no study in the literature examining the relationship between BBD and pelvic angle, femoral anteversion angle, femoral internal/external rotation angle ratio and hip muscle strength ratios in children with bladder-bowel dysfunction. Considering the close relationship between pelvis position, hip muscle strength, and femoral anteversion with the pelvic floor, investigators think that this relationship should be evaluated in children with BBD and will contribute to the literature.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT05182671
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05182671 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Halil Tugtepe
- Last refreshed: 12 February 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05182671.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing